• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Distalmotion gets FDA nod to expand Dexter surgical robot indications to gynecology

Distalmotion gets FDA nod to expand Dexter surgical robot indications to gynecology

June 16, 2026 By Sean Whooley

Dexter in use WEB
In Dexter-assisted procedures, the surgeon and the open console are in the sterile field. [Image courtesy of Distalmotion]
Distalmotion announced today that it received FDA 510(k) clearance for its Dexter surgical robot in a range of gynecology procedures.

Clearance covers sacrocolpopexy, sacrocervicopexy, sacrohysteropexy, and endometriosis resection. This marks the second clearance for Dexter in gynecology and the system’s fourth overall. Cleared gynecology procedures include hysterectomy and salpingo-oophorectomy. Its indications also include general surgery, covering inguinal hernia repair and cholecystectomy.

The company announced that it submitted Dexter for its latest indications just over two months ago.

Lausanne, Switzerland-based Distalmotion — one of 10 surgical robotics companies you need to know — designed Dexter to deliver robotic benefits to more hospitals, outpatient departments and ambulatory surgical centers (ASCs). The modular, small-format, open system delivers simplicity and straightforwardness, plus more accessibility, Distalmotion says.

Dexter can work natively with third-party 3D imaging systems, energy devices, vessel sealers and other laparoscopic devices. It features a suite of fully wristed, single-use instruments. These instruments offer dexterity, precision of movement, reliable instrument performance and lower reprocessing requirements.

(Learn more about Distalmotion, Dexter and the surgical robotics space in our MassDevice Surgical Robotics Special Report. Download the report for free here.)

With its latest indications, Dexter enables ASC administrators to expand their gynecologic surgery service line. It helps to meet demand for robotics in women’s health and efficiency metrics.

The company recently secured significant funding to support its efforts to bring Dexter to ASCs. CEO Greg Roche recently spoke about the ASC push on the DeviceTalks Weekly Podcast.

In parallel with the coming commercial expansion for these procedures, Distalmotion continues to advance its clinical pipeline. It currently has Dexter under evaluation in an FDA investigational device exemption (IDE) study for myomectomy.

“Securing FDA clearance for these additional GYN indications is another important milestone for the DEXTER program,” said Greg Roche, CEO of Distalmotion. “By enabling a comprehensive GYN service line, we are empowering care teams to maximize their workflows and deliver the combined benefits of robotics and same-day care to a broader patient population.”

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Gynecological, Health Technology, Regulatory/Compliance, Robotic-Assisted, Surgical, Surgical Robotics, Women's Health Tagged With: Distalmotion, FDA

More recent news

  • Boston Scientific continues to make progress on cyberattack recovery
  • Edwards Lifesciences, Medtronic score CMS win for TAVR
  • Stryker still working through cyberattack after-effects, stock down more than 10% this week
  • Siemens Healthineers completes $44M R&D, manufacturing site expansion
  • Next-gen Apple Watch Ultra 4 includes new health features

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy